Abstract
No public abstract is available from the verified source records.
Marguerite Massinga Loembe, Edlom P Tchadie, Selidji T Agnandji
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Mapping the zoonotic niche of Ebola virus disease in Africa
10.7554/elife.04395 · 2014
Predicting the spatiotemporal evolution of HIV/AIDS in Africa: a retrospective analysis of epidemiological trends
2026
The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa
10.1371/journal.pone.0257049 · 2021
Fostering prevention and care delivery services capability on HIV pandemic and Ebola outbreak symbiosis in Africa
10.3855/jidc.6875 · 2016
Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
10.1016/s2352-3018(26)00118-9 · 2026
Bundibugyo virus disease outbreak in DR Congo: current trajectory and potential risk for a Pandemic Emergency
10.1016/s1473-3099(26)00298-7 · 2026
Ebola vaccines for mass immunisation in affected regions
10.1016/s1473-3099(21)00226-7 · 2022
Readiness in preventing filovirus epidemics by use of the marketed vaccines against Zaire Ebola virus disease as prototypes
10.1016/s1473-3099(24)00297-4 · 2024
Cross-reactive Bundibugyo antibody responses after receipt of licensed Ebola vaccines
10.1056/nejmc2608018 · 2026
No additional external references are available.